← Back
$TRML All transactions

Tourmaline Bio, Inc.

M

$ Value

$0

Shares

25,316

Price

$0

Filed

Oct 24

Insider

Name

Kulkarni Sandeep Chidambar

Title

CEO

CIK

0001945691

Roles

Director Officer

Transaction Details

Transaction Date

2025-10-22

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

503,478

Footnotes

These shares are held by Gilead Capital, LP ("Gilead"). The Reporting Person's spouse is a partner of Gilead and shares voting and investment power with respect to the shares held by Gilead, and therefore the Reporting Person may be deemed an indirect beneficial owner of these shares. This report is not an admission that the Reporting Person is an indirect beneficial owner of these shares for purposes of Section 16 or for any other purpose. | The shares subject to the option vested as to 25% of the shares on June 14, 2024 with the remainder vesting in the following 36 equal monthly installments, subject to the Reporting Person's continued service on each such vesting date.

Filing Info

Accession No.

0001945691-25-000004

Form Type

4

Issuer CIK

0001827506

Kulkarni Sandeep Chidambar's History

Date Ticker Type Value
2026-04-01 ZURA A $0
2026-01-21 ZURA A $0
2025-10-28 TRML U
2025-10-28 TRML D
2025-10-28 TRML U
2025-10-28 TRML D
2025-10-28 TRML D
2025-10-28 TRML D
2025-10-22 TRML M $200K
2025-10-22 TRML M $0

Other Insiders at TRML (90d)

No other insider activity at this issuer in the last 90 days.